Antiviral effects of virazole in chronic hepatitis B surface antigen-seropositive chimpanzees
- PMID: 984798
- PMCID: PMC429791
- DOI: 10.1128/AAC.10.3.571
Antiviral effects of virazole in chronic hepatitis B surface antigen-seropositive chimpanzees
Abstract
Virazole (Ribavirin, ICN 1229), a broad-spectrum, antiviral chemotherapeutic agent was used to treat two adult chronically hepatitis B surface antigen (HB(s) Ag)-seropositive chimpanzees. No significant change in serum hepatitis B surface antigen was noted and no adverse reactions were observed. The role of viral replication in the chronic carrier state of hepatitis B is discussed.
Similar articles
-
Hepatitis B outbreak among chimpanzees at the London Zoo.Lancet. 1978 Sep 23;2(8091):652-4. doi: 10.1016/s0140-6736(78)92761-7. Lancet. 1978. PMID: 80578
-
[Action of an anti-viral on the Australia antigen in patients with hepatitis A virus and in healthy carriers].G E N. 1977 Jan-Mar;31(3):149-55. G E N. 1977. PMID: 97122 Portuguese.
-
Hepatitis B e-antigen and its correlation with other serological markers in chimpanzees.Infect Immun. 1979 May;24(2):352-6. doi: 10.1128/iai.24.2.352-356.1979. Infect Immun. 1979. PMID: 457278 Free PMC article.
-
[What should a vaccine against hepatitis B be like?].Vopr Virusol. 1978 Nov-Dec;(6):643-9. Vopr Virusol. 1978. PMID: 86238 Review. Russian. No abstract available.
-
Hepatitis B "e" antigen: a review.Indian J Pathol Microbiol. 1979 Apr;22(2):199-205. Indian J Pathol Microbiol. 1979. PMID: 385495 Review. No abstract available.
Cited by
-
Ribavirin and inosiplex: a review of their present status in viral diseases.Drugs. 1981 Aug;22(2):111-28. doi: 10.2165/00003495-198122020-00002. Drugs. 1981. PMID: 6167418 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources